Teva is investing heavily in its biotechnological production site in Ulm. On behalf of BIOPRO Baden-Württemberg, Walter Pytlik spoke with Dr. Hermann Allgaier, CEO of Teva Biotech, about the importance of biotechnology for the Group and about Teva in general. The company is headquartered in Israel.
In cooperation with the University of Mainz, the Springer publishing house is now offering distance learning courses for laboratory and technical assistants who wish to study while they are working. The courses lead to a Bachelor of Science degree. The successful programme for ambitious non-academics is being developed in several Baden-Württemberg cities.
Eight members of the Bundestag from Baden-Württemberg attended the Parliamentary Breakfast on 21st September 2016 in Berlin where information was presented on the performance of the biotechnology sector in Baden-Württemberg. The politicians also discussed with entrepreneurs ways of improving general conditions in the sector.
On December 6th, 2016, BIOPRO Baden-Württemberg together with Alsace BioValley and the generous support of Catalent Pharma Solutions will host a Meet & Match on "Challenges in Early Drug Development and Innovation in Drug Delivery" in Karlruhe.